company update today...so, some results before these very soon conferences ? pretty optimistic here, of course it's a longer play but some upside action is always welcome...potentially, maybe, possibly soon, just around the corner etc...hehe.
CALGARY, Alberta, Oct. 28, 2020 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its participation in two upcoming virtual conferences in November 2020.
The first presentation as an invited speaker is at the Meridian Clinical Trials Conference on Tuesday, November 3 rd at 2:30 pm Central time. This presentation is associated with XORTX’s ADPKD program and XRx-008 and is entitled “Orphan Drug Development Using the 505(b)2 Pathway”.
The second invited speaker presentation is the World Anti-Viral Congress – COVID-19 and Emerging Diseases Session on Thursday, November 12 th at 2:40 pm Eastern time and is entitled “XRx-101 As a Treatment for Coronavirus – A Strategy to Decrease Acute Kidney Injury, Co-morbidity and Mortality”.
Dr. Allen Davidoff, XORTX’s President and CEO stated, “As the Company awaits the completion of the clinical trial being conducted at Mt. Sinai, New York, as announced in our press release of August 4 th , we are pleased to be an invited presenter at both of these conferences with global audiences composed of clinicians, drug development professionals, investors and pharmaceutical companies."
https://stockhouse.com/news/press-releases/2020/10/28/xortx-participation-in-virtual-conferences